Key statistics
On Friday, Arbutus Biopharma Corp (I9DN:STU) closed at 3.43, -17.16% below its 52-week high of 4.14, set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.36 |
---|---|
High | 3.43 |
Low | 3.36 |
Bid | 3.45 |
Offer | 3.58 |
Previous close | 3.43 |
Average volume | 400.00 |
---|---|
Shares outstanding | 189.49m |
Free float | 147.39m |
P/E (TTM) | -- |
Market cap | 710.59m USD |
EPS (TTM) | -0.4259 USD |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Announcements
- Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- Arbutus to Report Third Quarter 2024 Financial Results and Provide Corporate Update
- Arbutus Announces Multiple Abstracts Highlighting Imdusiran Data Accepted for Presentation at AASLD - The Liver Meeting® 2024
- Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
- Arbutus to Participate in Two Upcoming Investor Conferences
- Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
- Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
- Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
- Arbutus to Participate in Jefferies Global Healthcare Conference
More ▼